Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Moodys
Dow
Express Scripts
Merck

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Pharmalucence Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for PHARMALUCENCE, and what generic and branded alternatives to PHARMALUCENCE drugs are available?

PHARMALUCENCE has fifteen approved drugs.



Summary for Pharmalucence
US Patents:0
Tradenames:15
Ingredients:14
NDAs:15

Drugs and US Patents for Pharmalucence

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmalucence SELENOMETHIONINE SE 75 selenomethionine se-75 INJECTABLE;INJECTION 017322-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Pharmalucence TECHNETIUM TC 99M SESTAMIBI technetium tc-99m sestamibi kit INJECTABLE;INJECTION 079157-001 Jul 10, 2009 AP RX No No   Start Trial   Start Trial
Pharmalucence IODOHIPPURATE SODIUM I 131 iodohippurate sodium i-131 INJECTABLE;INJECTION 017313-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Pharmalucence HEPATOLITE technetium tc-99m disofenin kit INJECTABLE;INJECTION 018467-001 Mar 16, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Colorcon
McKinsey
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.